The identification of FERM domain protein in serum infected with Plasmodium berghei

Aditya, 2013, Advances in nanomedicines for malaria treatment, Adv. Colloid Interface Sci., 201⿿202, 1, 10.1016/j.cis.2013.10.014 Wernsdorfer, 2003, Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology, Curr. Opin. Infect. Dis., 16, 553, 10.1097/00001432-200312000-00007 White, 2004, Antimalarial drug resistance, J. Clin. Invest., 113, 1084, 10.1172/JCI21682 Marsh, 1998, Malaria disaster in Africa, Lancet, 352, 924, 10.1016/S0140-6736(05)61510-3 Acharya, 2009, A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax, Proteomics Clin. Appl., 3, 1314, 10.1002/prca.200900090 Fontaine, 2012, Plasmodium falciparum infection-induced changes in erythrocyte membrane proteins, Parasitol. Res., 110, 545, 10.1007/s00436-011-2521-2 Ray, 2011, Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead, Proteomics, 11, 2139, 10.1002/pmic.201000460 Anderson, 2002, The human plasma proteome: history, character, and diagnostic prospects, Mol. Cell. Proteomics, 1, 845, 10.1074/mcp.R200007-MCP200 de Souza, 2010, Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease, Parasitology, 137, 755, 10.1017/S0031182009991715 Vathsala, 2012, Curcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulation, PLoS One, 7, e29442, 10.1371/journal.pone.0029442 Lillehoj, 1996, Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites, Clin. Microbiol. Rev., 9, 349, 10.1128/CMR.9.3.349 Chishti, 1998, The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane, Trends Biochem. Sci., 23, 281, 10.1016/S0968-0004(98)01237-7 Pearson, 2000, Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain, Cell, 101, 259, 10.1016/S0092-8674(00)80836-3 Leto, 1984, A structural model of human erythrocyte protein 4.1, J. Biol. Chem., 259, 4603, 10.1016/S0021-9258(17)43089-4 Rees, 1990, Sequence and domain structure of talin, Nature, 347, 685, 10.1038/347685a0 Wernig, 2008, The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes, Blood, 111, 3751, 10.1182/blood-2007-07-102186 Maier, 2009, Malaria parasite proteins that remodel the host erythrocyte, Nat. Rev. Microbiol., 7, 341, 10.1038/nrmicro2110 Lustigman, 1990, The mature-parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum associates with the erythrocyte membrane skeletal protein, band 4.1, Mol. Biochem. Parasitol., 38, 261, 10.1016/0166-6851(90)90029-L Maier, 2008, Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes, Cell, 134, 48, 10.1016/j.cell.2008.04.051 Waller, 2003, Mature parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum binds to the 30-kDa domain of protein 4.1 in malaria-infected red blood cells, Blood, 102, 1911, 10.1182/blood-2002-11-3513 MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nat. Rev. Mol. Cell. Biol., 4, 566, 10.1038/nrm1151 Hettmann, 2000, A dibasic motif in the tail of a class XIV apicomplexan myosin is an essential determinant of plasma membrane localization, Mol. Biol. Cell., 11, 1385, 10.1091/mbc.11.4.1385